Bryce Matthewson



Bryce has experience in both contentious and non-contentious matters across a range of IP rights and technical areas. Prior to undertaking his legal studies, Bryce obtained a degree in Chemistry and Applied Chemistry.  He has represented clients in the pharma and biotech field as well as in the gaming, banking and FMCG sectors.

He has particular experience as a patent litigator having conducted litigation across a wide range of technology areas in the UK and Europe, and prior to joining Powell Gilbert, South Africa and other African countries.

Bryce joined Powell Gilbert in 2016.

Key cases

  • Ansell v Reckitt Benckiser (synthetic polyisoprene products)

  • Eli Lilly v Eisai (Alzheimer therapies)

  • Samsung Bioepis & Biogen v AbbVie (adalimumab)